Azoy Alexander 4
4 · Arcus Biosciences, Inc. · Filed Dec 4, 2024
Insider Transaction Report
Form 4
Azoy Alexander
Chief Accounting Officer
Transactions
- Sale
Common Stock
2024-12-02$15.32/sh−201$3,079→ 19,070 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024.
- [F2]Consists of 201 shares purchased on 11/29/2024 through the Company's Employee Stock Purchase Plan.